Impact of "Off-Label" Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 101, Issue 3, 2008, Pages 293-299

  Roy, Probal ^a   Buch, Ashesh N ^a   Javaid, Aamir ^a   Okabe, Teruo ^a   Raya, Vikram ^a   Pinto Slottow, Tina L ^a   Steinberg, Daniel H ^a   Smith, Kimberly ^a   Xue, Zhenyi ^a   Gevorkian, Natalie ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DRUG LABELING; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RETREATMENT; RETROSPECTIVE STUDIES; SAFETY; UNITED STATES;

EID: 38549111499     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.08.048     Document Type: Article

References (22)

1. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiake D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. ™ Sirolimus-eluting Coronary Stent on RAPTOR. Over-the-Wire Delivery System and CYPHER Sirolimuseluting Coronary Stent on RAPTORRAIL Rapid Exchange Delivery System. Cordis Coporation; 2003. P020026. Available at http://www.fda.gov/cdrh/PDF2/p020026c.pdf. Accessed November 16, 2007.
4. Intructions for use. TAXUS Paclitaxel-Eluting Coronary Stent System: Monorail and Over-the-Wire Coronary Stent Delivery System. Boston Scientific; March 2003. Available at http://www.fda.gov/ohrms/dockets/ac/03/briefing/4005b1_03_Labeling.pdf. Accessed November 16, 2007.
5. Kim Y.H., Park S.W., Lee C.W., Hong M.K., Gwon H.C., Jang Y., Lee M.M., Koo B.K., Oh D.J., Seung K.B., Tahk S.J., Yoon J., and Park S.J. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Catheter Cardiovasc Interv 67 (2006) 181-187
6. Tsagalou E., Chieffo A., Iakovou I., Ge L., Sangiorgi G.M., Corvaja N., Airoldi F., Montorfano M., Michev I., and Colombo A. Multiple overlapping drug-eluting stents to treat diffuse disease of the left descending coronary artery. J Am Coll Cardiol 45 (2005) 1570-1573
7. Aoki J., Ong A.T., Rodriguez Granillo G.A., McFadden E.P., van Mieghem C.A., Valgimigli M., Tsuchida K., Sianos G., Regar E., de Jaegere P.P., van der Giessen W.J., de Feyter P.J., van Domburg R.T., and Serruys P.W. "Full metal jacket" (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 150 (2005) 994-999
8. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and mid-term outcome. J Am Coll Cardiol 45 (2005) 989-994
9. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Convens C., Bruining N., Van den Branden F., and Van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48 (2006) 2423-2431
10. Liistro F., Fineschi M., Angioli P., Sinicropi G., Falsini G., Gori T., Ducci K., Bravi A., and Bolognese L. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. J Am Coll Cardiol 48 (2006) 270-275
11. Holmes Jr. D.R., Teirstein P., Satler L., Sketch M., O'Malley J., Popma J.J., Kuntz R.E., Fitzgerald P.J., Wang H., Caramanica E., Cohen S.A., and SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 295 (2006) 1264-1273
12. Pasceri V., Patti G., Speciale G., Pristipino C., Richichi G., and Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 153 (2007) 749-754
13. Park S.J., Kim Y.H., Lee B.K., Lee S.W., Lee C.W., Hong M.K., Kim J.J., Mintz G.S., and Park S.W. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
14. Tsagalou E., Stancovic G., Iakovou I., Melzi G., Cosgrave J., Ge L., Michev I., Chieffo A., Airoldi F., Carlino M., Montorfano M., and Colombo A. Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug eluting stents. Am J Cardiol 97 (2006) 187-191
15. Seung K.B., Kim Y.H., Park D.W., Lee B.K., Lee C.W., Hong M.K., Kim P.J., Chung W.S., Tahk S.J., Park S.W., and Park S.J. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. J Am Coll Cardiol 46 (2005) 787-792
16. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1455
17. Pfisterer M., Brunner-La Rocca H., Buser P., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
18. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., Kutys R., Skorija K., Gold H.K., and Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
19. Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., and Peterson E.D. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). Am J Cardiol 97 (2006) 1478-1481
20. Beohar N., Davidson C.J., Kip K.E., Goodreau L., Vlachos H.A., Meyers S.N., Benzuly K.H., Flaherty J.D., Ricciardi M.J., Bennett C.L., and Williams D.O. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
21. Win H.K., Caldera A.E., Maresh K., Lopez J., Rihal C.S., Parikh M.A., Granada J.F., Marulkar S., Nassif D., Cohen D.J., Kleiman N.S., and EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
22. Herz I., Moshkovitz Y., Loberman D., Uretzky G., Braunstein R., Hendler A., Zivi E., Ben-Gal Y., and Mohr R. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Ann Thorac Surg 80 (2005) 2086-2090